Search clinical trials for: Mucopolysaccaride polysulfate (MPS)
Total 353 results
-
University of MelbourneAlcon Research; Clinical Vision Research AustraliaCompletedMyopia | HyperopiaAustralia
-
Abbott Medical OpticsCompletedAstigmatism | Myopia | HyperopiaUnited States
-
Poitiers University HospitalCompleted
-
Assistance Publique - Hôpitaux de ParisTerminated
-
Abbott Medical OpticsCompletedCorneal StainingUnited States
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaboratorsCompletedMucopolysaccharidosesUnited States
-
Mackay Memorial HospitalSanofi Taiwan Co. LtdRecruiting
-
Abbott Medical OpticsWithdrawnAstigmatism | Myopia | Hyperopia
-
Innovative MedicalCompletedCorneal StainingUnited States
-
UCB PharmaCompleted
-
UCB PharmaCompletedDiabetic NeuropathyUnited States
-
UCB PharmaCompletedPartial Seizures With or Without Secondary GeneralizationGermany
-
University of North Carolina, Chapel HillMetagenics, Inc.; North Carolina Translational and Clinical Sciences InstituteCompleted
-
UCB PharmaCompletedDiabetic NeuropathiesUnited States
-
UCB PharmaCompletedEpilepsies, PartialUnited States
-
Institut National de la Santé Et de la Recherche...RecruitingMucopolysaccharidosis I | Mucopolysaccharidosis II | Mucopolysaccharidosis VI | Mucopolysaccharidosis III | Mucopolysaccharidosis IV | Mucopolysaccharidosis VII | Multiple Sulfatase Deficiency Disease | Mucopolysaccharidosis IXFrance
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaboratorsCompletedMucopolysaccharidosis Type IUnited States
-
Seoul National University Bundang HospitalCompleted
-
Innovative MedicalCompletedPatient Comfort | Lens CleanlinessUnited States
-
National MPS SocietyMediResource Inc.TerminatedMucopolysaccharidosis I | Mucopolysaccharidosis II | Mucopolysaccharidoses | Mucopolysaccharidosis VI | Mucopolysaccharidosis IVUnited States
-
Immusoft of CA, Inc.RecruitingMucopolysaccharidosis IH/S | Mucopolysaccharidosis ISUnited States
-
Medinova AGCompletedPhlebitis | ThrombophlebitisThailand
-
Sigilon Therapeutics, Inc.WithdrawnMPS I | MPS1-S | MPS1-HSBrazil, United Kingdom
-
ShireCompletedSanfilippo Syndrome Type BUnited States, United Kingdom, Germany
-
Medtronic - MITGTerminated
-
Lundquist Institute for Biomedical Innovation at...TerminatedMucopolysaccharidosis I | Mucopolysaccharidosis II | Mucopolysaccharidosis VIUnited States
-
Lallemand Health SolutionsNutrasource Pharmaceutical and Nutraceutical Services, Inc.CompletedMenopauseUnited States
-
Istanbul Bilgi UniversityUnknown
-
Genzyme, a Sanofi CompanyBioMarin/Genzyme LLCCompletedMucopolysaccharidosis I | Scheie Syndrome | Hurler Syndrome | Hurler-Scheie SyndromeJapan
-
Otsuka Pharmaceutical Co., Ltd.CompletedIdiopathic Restless Legs SyndromeJapan
-
Alcon ResearchCompletedHealthy Contact Lens WearersUnited States
-
ArmaGen, IncCompletedMucopolysaccharidosis IUnited States
-
NovartisCompleted
-
Duke UniversityRecruiting
-
Denali Therapeutics Inc.RecruitingMucopolysaccharidosis IIUnited States, Spain, United Kingdom, Czechia, France, Canada, Italy, Belgium, Netherlands, Germany, Argentina, Sweden, Turkey, Colombia, Brazil
-
University of Maryland, BaltimoreActive, not recruitingPain, Postoperative | Opioid UseUnited States
-
University of California, San FranciscoDuke UniversityRecruitingWolman Disease | MPS IVA | Pompe Disease Infantile-Onset | Gaucher Disease, Type 2 | MPS VI | MPS I | Gaucher Disease, Type 3 | MPS II | Mps VIIUnited States
-
Nationwide Children's HospitalSanfilippo Children's Research Foundation; The Sanfilippo Research Foundation; The Children's Medical Research FoundationCompletedMucopolysaccharidosis Type IIIA | Mucopolysaccharidosis Type IIIBUnited States
-
University of Maryland, BaltimoreEnrolling by invitation
-
Denali Therapeutics Inc.Enrolling by invitationMucopolysaccharidosis IIUnited States, Canada, Belgium, Czechia, Netherlands
-
Novartis PharmaceuticalsCompletedPatients Successfully Completing the 12-month Treatment Period of the Core Study (de Novo Heart Recipients) Who Were Interested of Being Treated With EC-MPS
-
Allievex CorporationActive, not recruitingMucopolysaccharidosis Type IIIBUnited States, Germany, Spain, Argentina, Australia, Brazil, Colombia, Taiwan, Turkey
-
NovartisCompleted
-
National Eye Institute (NEI)UnknownMacular Degeneration | Choroidal Neovascularization | Histoplasmosis
-
REGENXBIO Inc.Withdrawn
-
Green Cross CorporationCompletedMucopolysaccharidosis IIKorea, Republic of
-
Masonic Cancer Center, University of MinnesotaRecruitingMucopolysaccharidosis Type I | Hematopoietic Cell TransplantationUnited States